The digital vivarium for preclinical research
Vium is a biotechnology company that built the first fully digital end-to-end Digital Vivarium platform, using computer vision, machine learning, and sensor technologies to non-invasively transform preclinical in vivo drug research. Founded in 2013 as Mousera by Timothy Robertson and Joe Betts-Lacroix, Vium developed digital biomarkers to accelerate drug discovery and improve animal welfare in research settings. The company was acquired by Recursion Pharmaceuticals in July 2020.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account